Some antiviral and antineoplastic drugs, and other pharmaceutical agents

Evaluates the carcinogenic risks to humans posed by the use of four antiretroviral agents four DNA topoisomerase II inhibitors used in the treatment of cancer and an additional three pharmaceutical agents (hydroxyures phenolphthalein and vitamin K sub

Bibliographic Details
Corporate Authors: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, World Health Organization
Format: Book
Language:English
Published: Lyon, France : Geneva : IARC ; Distributed by IARC Press and by the World Health Organization, 2000
Lyon, France : Geneva : IARC ; World Health Organization Distribution and Sales, 2000
Lyon, France : IARC, 2000
Lyon, France : 2000
Series:IARC monographs on the evaluation of carcinogenic risks to humans v. 76
IARC monographs on the evaluation of carcinogenic risks to humans, v. 76
IARC monographs on the evaluation of carcinogenic risks to humans ; v. 76
IARC monographs on the evaluation of carcinogenic risks to humans v. 76
IARC monographs on the evaluation of carcinogenic risks to humans v. 76
Subjects:

Internet

Yale University

Holdings details from Yale University
Call Number: RC268.57 I57 v.76

Massachusetts Institute of Technology

Holdings details from Massachusetts Institute of Technology
Call Number: RC268.57.I57 v.76

Johns Hopkins University

Holdings details from Johns Hopkins University
Call Number: RC262 .I61 v.76 2000

Harvard University

Holdings details from Harvard University
Call Number: QZ 202 I12 v.76 2000

Duke University

Holdings details from Duke University
Call Number: QZ206 In85 v.76 2000

Columbia University

Holdings details from Columbia University
Call Number: Serial I

University of Pennsylvania

Holdings details from University of Pennsylvania
Call Number: RC268.5 .I61m v.76 2000